ArticleJournal of personalized medicine2023

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.

Wojciech A Cieślikowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.